The Women’s Health Initiative Randomized Trials and Clinical Practice
JAMA · 28.05.2024 · 331 (20) · 1748
DOI: 10.1001/jama.2024.6542 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift JAMA, erschienen am 28.05.2024. Verfasst von JoAnn E Manson und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Hauptthemen laut MEDLINE: Breast Neoplasms, Cardiovascular Diseases, Dietary Supplements, Estrogen Replacement Therapy. Die Arbeit wurde bisher 177-mal zitiert (Crossref) und nennt 64 Literaturangaben.
Abstract (Originalsprache)
Importance Approximately 55 million people in the US and approximately 1.1 billion people worldwide are postmenopausal women. To inform clinical practice about the health effects of menopausal hormone therapy, calcium plus vitamin D supplementation, and a low-fat dietary pattern, the Women’s Health Initiative (WHI) enrolled 161 808 postmenopausal US women (N = 68 132 in the clinical trials) aged 50 to 79 years at baseline from 1993 to 1998, and followed them up for up to 20 years. Observations The WHI clinical trial results do not support hormone therapy with oral conjugated equine estrogens plus medroxyprogesterone acetate for postmenopausal women or conjugated equine estrogens alone for those with prior hysterectomy to prevent cardiovascular disease, dementia, or other chronic diseases. However, hormone therapy is effective for treating moderate to severe vasomotor and other menopausal symptoms. These benefits of hormone therapy in early menopause, combined with lower rates of adverse effects of hormone therapy in early compared with later menopause, support initiation of hormone therapy before age 60 years for women without contraindications to hormone therapy who have bothersome menopausal symptoms. The WHI results do not support routinely recommending calcium plus vitamin D supplementation for fracture prevention in all postmenopausal women. However, calcium and vitamin D are appropriate for women who do not meet national guidelines for recommended intakes of these nutrients through diet. A low-fat dietary pattern with increased fruit, vegetable, and grain consumption did not prevent the primary outcomes of breast or colorectal cancer but was associated with lower rates of the secondary outcome of breast cancer mortality during long-term follow-up. Conclusions and Relevance For postmenopausal women, the WHI randomized clinical trials do not support menopausal hormone therapy to prevent cardiovascular disease or other chronic diseases. Menopausal hormone therapy is appropriate to treat bothersome vasomotor symptoms among women in early menopause, without contraindications, who are interested in taking hormone therapy. The WHI evidence does not support routine supplementation with calcium plus vitamin D for menopausal women to prevent fractures or a low-fat diet with increased fruits, vegetables, and grains to prevent breast or colorectal cancer. A potential role of a low-fat dietary pattern in reducing breast cancer mortality, a secondary outcome, warrants further study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
- Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles.
- National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.
- Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California.
- Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington.
- Stanford Prevention Research Center, Department of Medicine, Stanford University, Stanford, California.
Zitieren
APA
Manson, J. E., Crandall, C. J., Rossouw, J. E., Chlebowski, R. T., Anderson, G. L., Stefanick, M. L., Aragaki, A. K., Cauley, J. A., Wells, G. L., LaCroix, A. Z., Thomson, C. A., Neuhouser, M. L., Van Horn, L., Kooperberg, C., Howard, B. V., Tinker, L. F., Wactawski-Wende, J., Shumaker, S. A., & Prentice, R. L. (2024). The Women’s Health Initiative Randomized Trials and Clinical Practice. JAMA, 331(20), 1748. https://doi.org/10.1001/jama.2024.6542
Vancouver
Manson JE, Crandall CJ, Rossouw JE, Chlebowski RT, Anderson GL, Stefanick ML, et al. The Women’s Health Initiative Randomized Trials and Clinical Practice. JAMA. 2024;331(20):1748. doi:10.1001/jama.2024.6542
BibTeX
@article{Manson2024,
author = {Manson, JoAnn E and Crandall, Carolyn J and Rossouw, Jacques E and Chlebowski, Rowan T and Anderson, Garnet L and Stefanick, Marcia L and Aragaki, Aaron K and Cauley, Jane A and Wells, Gretchen L and LaCroix, Andrea Z and Thomson, Cynthia A and Neuhouser, Marian L and Van Horn, Linda and Kooperberg, Charles and Howard, Barbara V and Tinker, Lesley F and Wactawski-Wende, Jean and Shumaker, Sally A and Prentice, Ross L},
title = {The Women’s Health Initiative Randomized Trials and Clinical Practice},
journal = {JAMA},
year = {2024},
volume = {331},
number = {20},
pages = {1748},
doi = {10.1001/jama.2024.6542}
}
EUVIMED